http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106727453-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-075 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-075 |
| filingDate | 2017-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106727453-B |
| titleOfInvention | Application of a compound in preparing medicine for treating hypothyroidism |
| abstract | The invention discloses a new use of a bromophenol compound 3-bromo-4-[3-bromo-4,5-dihydroxybenzyl]-5-(ethoxymethyl)benzene-1,2-diol, which can improve hypothyroidism The fasting serum thyroid hormone (T3, T4, FT3, FT4) levels of the disease model animals can be used to reduce the serum thyroid-stimulating hormone (TSH) levels, which can be used to prepare drugs for treating hypothyroidism. |
| priorityDate | 2017-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 28.